Shen Hao, Wang Qiao-jie, Zhang Xian-long, Jiang Yao, Wang Qi, Chen Yun-su, Shao Jun-jie
Department of Orthopedic Surgery, Shanghai Jiaotong University, Shanghai, China.
Zhonghua Yi Xue Za Zhi. 2012 Sep 18;92(35):2456-9.
The question of whether a total joint arthroplasty should be attempted in a patient with a current or previous infection of tuberculosis continues to arouse controversy. The aim of this report was to evaluate the clinical outcomes of cementless total hip arthroplasty for the treatment of advanced tuberculosis of hip.
A total of 14 patients with advanced tuberculosis of hip treated by cementless total hip arthroplasty were retrospectively analyzed. For the patients with a definite diagnosis of tuberculosis and elevated levels of CRP (C-reactive protein) and ESR (erythrocyte sedimentation rate) before surgery, preoperative antituberculous medications were prescribed for at least 2 weeks. The inflamed soft tissues and destroyed bones were completely curetted out at the time of operation. Twelve of 14 patients received one-stage cementless total hip arthroplasty after a thorough debridement. For the remaining 2 patients, two-stage strategy was taken with cement articulating spacer implanted after a thorough debridement and followed by cementless total hip arthroplasty at 6-8 months later. All patients were prescribed antituberculous medications postoperatively for the first 6 months.
The mean Harris Hip Score (HHS) was 36 preoperatively and 87 at the last follow-up. Within an average follow-up period of 49 months (range: 27 - 77), only one patient had reactivation of tuberculosis 7 months after primary THA (total hip arthroplasty) and received resection arthroplasty. Another 13 patients had no reactivation of tuberculosis and revealed stability by bone ingrowth on both socket and femoral stem.
Cementless total hip arthroplasty is a safe and effective procedure for advanced tuberculosis of hip. With a thorough debridement followed by a complete course of antituberculous chemotherapy, active tuberculous infection should not be considered a contraindication for THA. In patients whose diagnosis of tuberculosis is confirmed intraoperatively and with no preoperative antituberculous chemotherapy, or in those a thorough debridement can not be achieved, a two-stage surgery may be considered.
对于目前患有或既往有结核感染的患者是否应尝试进行全关节置换术这一问题,仍存在争议。本报告的目的是评估非骨水泥型全髋关节置换术治疗晚期髋关节结核的临床疗效。
回顾性分析14例接受非骨水泥型全髋关节置换术治疗的晚期髋关节结核患者。对于术前明确诊断为结核且CRP(C反应蛋白)和ESR(红细胞沉降率)水平升高的患者,术前给予抗结核药物治疗至少2周。手术时将发炎的软组织和破坏的骨质彻底刮除。14例患者中有12例在彻底清创后接受一期非骨水泥型全髋关节置换术。其余2例患者采用两阶段策略,在彻底清创后植入骨水泥关节间隔器,6 - 8个月后再行非骨水泥型全髋关节置换术。所有患者术后前6个月均给予抗结核药物治疗。
术前Harris髋关节评分(HHS)平均为36分,末次随访时为87分。在平均49个月(范围:27 - 77个月)的随访期内,仅1例患者在初次全髋关节置换术后7个月结核复发,接受了关节切除成形术。另外13例患者结核未复发,髋臼和股骨干均通过骨长入实现稳定。
非骨水泥型全髋关节置换术治疗晚期髋关节结核是一种安全有效的方法。在彻底清创并完成全程抗结核化疗后,活动性结核感染不应被视为全髋关节置换术的禁忌证。对于术中确诊为结核且术前未进行抗结核化疗的患者,或无法实现彻底清创的患者,可考虑采用两阶段手术。